Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension

Back

ESC Premium Access

Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension

Session: Pulmonary hypertension: progress in management, impact on outcomes

Topic: Pulmonary Hypertension

Speaker: Professor N. Galie (Bologna, IT)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Nazzareno Galie

Alma Mater Studiorum, University of Bologna, Bologna (Italy)

17 presentations

2 followers

9 more presentations in this session

Fast screening breath analysis for diagnostics of pulmonary hypertension.

Speaker: Assistant Professor A. Swinarew (Katowice, PL)

Phenomapping to detect non-invasively patients with combined postcapillary pulmonary hypertension

Speaker: Doctor O. Raitiere (Le Havre Cedex, FR)

Impact of comorbidity on outcome in CTD-associated pulmonary arterial hypertension: data from the Swedish Pulmonary Arterial Hypertension Registry

Speaker: Doctor C. Hjalmarsson (Gothenburg, SE)

Improved ten-year survival of systemic sclerosis-associated pulmonary arterial hypertension in the contemporary treatment era: a single centre retrospective study of 451 patients.

Speaker: Doctor H. Fayed (London, GB)

Comparison between paediatric and adult patients with pulmonary arterial hypertension

Speaker: Doctor E. Zuffa (Bologna, IT)

Access

Abstract

Access the full session

Pulmonary hypertension: progress in management, impact on outcomes

Speakers: Professor N. Galie, Assistant Professor A. Swinarew, Doctor O. Raitiere, Doctor C. Hjalmarsson, Doctor H. Fayed...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources